Healthcare Sector
Medical Laboratories Industry 
|
|
|
Data by Company within Medical Laboratories Industry
|
| |
Marketcap |
Revenues (TTM) |
Net Income (TTM) |
Employees |
| Company |
(Millions) |
(Millions) |
(Millions) |
Number |
| Alliance Healthcare Services, Inc |
$ 143 |
$ 524 |
$ 18 |
- |
| American Shared Hospital Services |
$ 17 |
$ 20 |
$ 3 |
- |
| Arrowhead Pharmaceuticals, Inc. |
$ 247 |
$ 23 |
$ -46 |
- |
| Bioanalytical Systems Inc |
$ 14 |
$ 24 |
$ -1 |
- |
| Biocept Inc |
$ 34 |
$ 5 |
$ -19 |
- |
| Cannlabs, Inc. |
- |
- |
$ 0 |
- |
| Cascadian Therapeutics, Inc. |
$ 196 |
- |
$ -27 |
- |
| Cannabis Science, Inc. |
$ 111 |
$ 0 |
$ -7 |
- |
| Cleveland Biolabs Inc |
$ 34 |
$ 3 |
$ -7 |
- |
| Cryo Cell International Inc |
$ 52 |
$ 24 |
$ -1 |
- |
| Caredx, Inc. |
$ 61 |
$ 47 |
$ -29 |
- |
| Cancer Genetics, Inc |
$ 64 |
$ 28 |
$ -19 |
- |
| China Health Industries Holdings, Inc. |
- |
$ 6 |
$ 2 |
- |
| Nuo Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Charles River Laboratories International Inc |
$ 5,174 |
$ 1,772 |
$ 166 |
- |
| Elite Data Services, Inc. |
$ 0 |
- |
$ -8 |
- |
| Quest Diagnostics Inc |
$ 14,437 |
$ 7,588 |
$ 754 |
45,000 |
| Dyax Corp |
- |
- |
$ 0 |
- |
| Enzo Biochem Inc |
$ 494 |
$ 106 |
$ 34 |
- |
| Exact Sciences Corp |
$ 4,795 |
$ 234 |
$ -141 |
- |
| Exelixis, Inc. |
$ 8,583 |
$ 320 |
$ 62 |
- |
| First Choice Healthcare Solutions, Inc. |
$ 28 |
$ 92 |
$ 1 |
- |
| Foundation Medicine, Inc. |
$ 1,410 |
$ 120 |
$ -158 |
- |
| Evolutionary Genomics, Inc. |
$ 6 |
$ 0 |
$ -1 |
- |
| Prolung Inc |
- |
- |
$ -3 |
- |
| Genomic Health Inc |
$ 1,082 |
$ 334 |
$ -5 |
- |
| Complete Genomics Inc |
- |
- |
$ 0 |
- |
| Geovax Labs, Inc. |
$ 3 |
$ 1 |
$ -2 |
- |
| Human Genome Sciences Inc |
- |
- |
$ 0 |
- |
| Icagen, Inc. |
- |
- |
$ 0 |
- |
| Icagen, Inc. |
- |
- |
$ 0 |
- |
| Icon Plc |
$ 6,183 |
$ 1,694 |
$ 261 |
- |
| Imaging3 Inc |
- |
$ 0 |
$ 2 |
- |
| Inc Research Holdings, Inc. |
$ 3,017 |
$ 1,571 |
$ 89 |
- |
| Incyte Corp |
$ 24,289 |
$ 1,306 |
$ -154 |
- |
| International Stem Cell Corp |
$ 6 |
$ 7 |
$ 0 |
- |
| Laboratory Corp Of America Holdings |
$ 15,900 |
$ 9,835 |
$ 760 |
36,000 |
| Luna Innovations Inc |
$ 44 |
$ 57 |
$ -2 |
- |
| Yield10 Bioscience, Inc. |
- |
- |
$ -3 |
68 |
| Medical Imaging Corp. |
$ 2 |
$ 7 |
$ -2 |
- |
| Miragen Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Mynd Analytics, Inc. |
$ 17 |
- |
$ 0 |
- |
| Nanoviricides, Inc. |
$ 79 |
- |
$ -9 |
- |
| National Research Corporation |
- |
$ 115 |
$ 23 |
- |
| National Research Corporation |
- |
- |
$ 0 |
- |
| Natera, Inc. |
$ 674 |
$ 318 |
$ -128 |
- |
| Nuo Therapeutics, Inc. |
- |
$ 8 |
$ -53 |
- |
| Invitae Corp |
$ 386 |
$ 40 |
$ -105 |
- |
| Nexeon Medsystems Inc |
- |
- |
$ -2 |
- |
| Oncothyreon Inc. |
- |
- |
$ 0 |
- |
| Opgen Inc |
$ 8 |
$ 3 |
$ -19 |
- |
| Pressure Biosciences Inc |
$ 4 |
$ 2 |
$ -4 |
- |
| Pacifichealth Laboratories Inc |
- |
- |
$ 0 |
- |
| Pieris Pharmaceuticals, Inc. |
$ 236 |
$ 7 |
$ -31 |
- |
| Psychemedics Corp |
$ 110 |
$ 43 |
$ 7 |
- |
| Pra Health Sciences, Inc. |
$ 4,926 |
$ 1,947 |
$ 100 |
- |
| Parexel International Corp |
$ 4,505 |
$ 2,442 |
$ 107 |
- |
| Prourocare Medical Inc. |
- |
- |
$ 0 |
- |
| Quintiles Ims Holdings, Inc. |
$ 21,134 |
$ 4,347 |
$ -212 |
- |
| Radnet, Inc. |
$ 524 |
$ 909 |
$ 11 |
- |
| Response Biomedical Corp |
- |
- |
$ 0 |
- |
| Sunshine Biopharma, Inc |
$ 11 |
- |
$ -3 |
- |
| Miragen Therapeutics, Inc. |
- |
$ 3 |
$ -19 |
- |
| Senomyx Inc |
$ 32 |
$ 20 |
$ -12 |
- |
| Sorrento Therapeutics, Inc. |
$ 94 |
$ 12 |
$ -68 |
- |
| Stallion Synergies, Inc |
- |
- |
$ 0 |
- |
| Dr. Tattoff, Inc. |
- |
- |
$ 0 |
- |
| Tenax Therapeutics, Inc. |
$ 10 |
- |
$ 42 |
- |
| Titanium Healthcare, Inc. |
- |
- |
$ 0 |
- |
| United Health Products, Inc. |
$ 31 |
$ 0 |
$ 0 |
- |
| Veracyte, Inc. |
$ 265 |
$ 72 |
$ -26 |
- |
| Vitro Diagnostics Inc, |
- |
- |
$ 0 |
- |
| Intrexon Corp |
$ 2,316 |
$ 201 |
$ -157 |
- |
| Medical Laboratories Industry |
$ 121,789 |
$ 36,234 |
$ 960 |
81,068 |
| Earnings |
|
Earnings |
|
Earnings |
|
Earnings Outlook increase
Looking into earnings estimates within the Medical Laboratories Industry in the current quarter, 100 % of companies, who provide earning guidance within Medical Laboratories Industry have increased their earnings outlook for the current fiscal year. But this falls short, as more corporations cut their earnings estimates. |
Earnings Guidance unchanged
In the same quarter, none of those companies, who issued earnings outlook, has reiterated its earnings estimates within the Medical Laboratories Industry. |
Earnings Estimates
decrease
There were no decreases in earnings estimates within Medical Laboratories Industry |
|
Expected
Eps Growth |
|
|
Eps
Expectation Revision |
|
 |
% Industry
Expected EPS Growth |
|
Total Ranking # Within Sector # |
|
|
|
% Industry
Earnings Outlook Revision |
|
Total Ranking # Within Sector # |
|
|
|
Revenue |
|
Revenue |
|
Revenue |
Sales Forecast increase
Within Medical Laboratories Industry there were no increases of sales guidance. |
Sales Expectations unchanged
Among companies who provide sales guidance within Medical Laboratories Industry 50 %, have reiterated own sales estimates for the current fiscal year. |
Sales Outlook decrease
On the negative side, 50 % of businesses within Medical Laboratories Industry, that provide top-line expectation, expect now to sell less, compare to the previous guidance. |
|
Expected
Revenue Growth |
|
|
Revenue
Expectation Revision |
|
|
|
% Industry
Expected Revenue Growth |
|
Total Ranking # Within Sector # |
|
|
|
% Industry
Revenue Outlook Revision |
|
Total Ranking # Within Sector # |
|
|
|
